Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study - Concepedia

Concepedia

Publication | Open Access

Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study

DOI Full Paper Access

29

Citations

13

References

2013

Year

Richard Follows, Neil G. Snowise, Shuyen Ho, Claire Ambery, Kevin Smart, B. McQuade

Respiratory Research

Abstract

Clinicaltrials.gov: NCT01147744.

References

	Year	Citations

Page 1